Prosecution Insights
Last updated: April 19, 2026
Application No. 16/913,615

PALATABILITY ENHANCERS FOR PET FOOD, METHOD OF PREPARATION AND USES THEREOF

Non-Final OA §103
Filed
Jun 26, 2020
Examiner
GLIMM, CARRIE LYNN STOFFEL
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Specialites Pet Food
OA Round
7 (Non-Final)
22%
Grant Probability
At Risk
7-8
OA Rounds
3y 10m
To Grant
38%
With Interview

Examiner Intelligence

Grants only 22% of cases
22%
Career Allow Rate
15 granted / 68 resolved
-42.9% vs TC avg
Strong +16% interview lift
Without
With
+15.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
35 currently pending
Career history
103
Total Applications
across all art units

Statute-Specific Performance

§101
3.1%
-36.9% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
8.7%
-31.3% vs TC avg
§112
32.7%
-7.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 68 resolved cases

Office Action

§103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 02 March 2026 has been entered. Status of Application Claims 11, 12, 17 and 18 are pending. Claims 1-10, 13-16 and 19 have been cancelled. The previous 112(b) rejections have been withdrawn in view of applicant’s amendments to the claims. The previous 103 rejections have been modified in view of applicant’s amendments to the claims. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 11-12 and 17 are rejected under 35 U.S.C. 103 as being unpatentable over Sunvold (US 2010/0303978 A1). Regarding claims 11-12 and 17, Sunvold discloses a process of making a pet food comprising extruding a mixture to form a core pellet, providing a coating, wherein the coating comprises a vitamin; and applying the coating to the core pellet to form a coated kibble (Abstract). Sunvold discloses the pet may be a dog [0020]. Sunvold discloses the coating is applied to increase animal preference of the food (a palatable dog food/obtaining a palatable dog food) [0039]. Sunvold discloses the kibble can be coated with a vitamin coating [0104] and the vitamin can be ascorbic acid (PECa) [0051]. Sunvold discloses the vitamin coating can include a palatant component [0104]. Sunvold does not require ascorbyl palmitate in the composition, therefore the process of Sunvold meets the claim limitation of ascorbyl palmitate is excluded as a derivative of ascorbic acid. Sunvold discloses the coating can comprise several coating components including 1-10 wt% a palatant component and the palatant can be liquid digest derived from chicken livers (a palatability enhancer in liquid form) [0058]. Sunvold discloses brewers dried yeast as an optional ingredient [0037] and yeast is therefore not a required ingredient. Sunvold does not disclose a specific embodiment with a coating comprising ascorbic acid and the palatant component of liquid digest derived from chicken livers, however, since Sunvold discloses the coating can comprise several components [0040] and the kibble can have more than one coating and each of these coatings can be comprised of any of the coating components described in the document [0041], it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to make a coating of ascorbic acid and the palatant component because Sunvold discloses making multiple coatings comprised of mixtures of the coating components disclosed. Sunvold’s disclosure of 1-10 wt% of the palatant component in the coating results in greater than 90-99 wt% of the coating comprising the ascorbic acid, which falls within the claimed range of 0.01-99.99 wt % of the PECa (ascorbic acid) in the PECb. Sunvold discloses the kibble can have more than one coating and each of these coatings can be comprised of any of the coating components described in the document [0041]. Sunvold discloses the coating can be a binder and the binder can be lipids and lipid derivatives such as plant and animal fats [0048]. Sunvold discloses the finished coated kibble comprises less than 0.2 wt% of the vitamin component [0110], which falls within the claimed range of 0.0016-0.3 wt%. Additionally, Sunvold discloses the coating from 10-20 wt% of the finished coated kibble and the coating can comprise 1-10 wt% palatant (animal digest) [0058], which results in a finished coated kibble comprising 0.1-2 wt% palatant (animal digest). When combined with the disclosure that the finished coated kibble comprises less than 0.2 wt% of the vitamin component, the finished coated kibble of Sunvold comprises 0.1-2.2 wt% of palatant and vitamin component combined (PECb), which falls within the claimed range of 0.001-5 wt%. Regarding the claim language “palatable dog food” this language is deemed to be an intended use of the composition prepared by the claimed method. In method claims, a claimed intended use must result in a manipulative difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. MPEP 2111.02. Given that the pet food of Sunvold is identical to that of the presently claimed in terms of process, it meets the intended use of the claimed method. Additionally, Sunvold discloses the coating is applied to increase animal preference of the food which is considered to provide a palatable dog food [0039]. Regarding the order of steps, Sunvold does not disclose the order of coating with the fat, palatant and vitamin component. However, selection of any order of performing process steps is prima facie obvious in the absence of new or unexpected results. MPEP 2144.04 IV. C. Claim 18 is rejected under 35 U.S.C. 103 as being unpatentable over Sunvold (US 2010/0303978 A1) as applied to claim 11 above, and further in view of Yamka (US 2012/0289598 A1). Regarding claim 18, Sunvold discloses the dog food of claim 11, including the coating comprising animal digest and ascorbic acid. Sunvold does not disclose the ascorbic acid salts. Yamka, in the field of enhancing palatability of edible food compositions for companion animals (Abstract), discloses the companion animal may be a dog [0027]. Yamka discloses the food may comprise antioxidants to stabilize the food and increase shelf life [0105] and the antioxidant may be vitamin C, ascorbic acid, or can be administered as ascorbic acid phosphate salts and cholesteryl salt which will function in a vitamin C like activity after ingestion by the pet [0107]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to substituted the ascorbic acid phosphate salts or cholestryl salt of Yamka for the ascorbic acid of Sunvold because Yamka discloses the ascorbic acid salts will function with vitamin C (ascorbic acid) like activity after ingestion by the pet and the substitution of equivalents known for the same purpose (here to provide vitamin C activity) is obvious. MPEP 2144.06 II. Response to Arguments Applicant's arguments filed 02 March 2026 have been fully considered but they are not persuasive. Applicant requests a reconsideration of the Rule 132 Declaration filed 26 September 2025 since the claims have been amended to be commensurate in scope with the experimental data presented with arguments towards unexpected results. Remarks p4. The argument as to unexpected results is not persuasive. The Declaration filed 26 September 2025 has been reconsidered. The arguments therein are not considered persuasive. The declaration argues, with respect to the previous arguments for unexpected results when ascorbic acid is included at rates higher than 0.0016% in the final feed, the experiment designed for the specification was chosen as to be the most scientifically valid by not changing the amount of the total palatability enhancer in the experimental test food vs the control test food. Declaration p2. The design choice for the experiment for consistency is appreciated, however regardless of the choice of experimental design, the data in the specification is not sufficient to show unexpected results to overcome the current art rejection. Applicant has not demonstrated unexpected results relative to the disclosure of Sunvold. Sunvold discloses the process of making the palatable dog food of claim 11, including all the recited method steps and quantities of ascorbic acid and palatants. In view of the foregoing, when all of the evidence is considered, the totality of the rebuttal evidence of nonobviousness fails to outweigh the evidence of obviousness. Applicant’s remaining arguments with respect to claims 11-12 and 17-18 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Remarks pp5-7. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CARRIE GLIMM whose telephone number is (571)272-2839. The examiner can normally be reached Monday-Thursday 10:30-6:30 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Michele L Jacobson/Primary Examiner, Art Unit 1793 /C.L.G./Examiner, Art Unit 1793
Read full office action

Prosecution Timeline

Jun 26, 2020
Application Filed
Apr 23, 2022
Non-Final Rejection — §103
Jul 26, 2022
Examiner Interview Summary
Jul 26, 2022
Applicant Interview (Telephonic)
Jul 28, 2022
Response Filed
Nov 02, 2022
Final Rejection — §103
Mar 07, 2023
Request for Continued Examination
Mar 09, 2023
Response after Non-Final Action
Apr 11, 2023
Response after Non-Final Action
Jun 06, 2023
Response after Non-Final Action
Sep 13, 2023
Non-Final Rejection — §103
Dec 05, 2023
Applicant Interview (Telephonic)
Dec 05, 2023
Examiner Interview Summary
Mar 20, 2024
Response after Non-Final Action
Mar 20, 2024
Response Filed
May 15, 2024
Final Rejection — §103
Aug 07, 2024
Response after Non-Final Action
Aug 07, 2024
Response after Non-Final Action
Aug 29, 2024
Response after Non-Final Action
Aug 29, 2024
Examiner Interview (Telephonic)
Nov 20, 2024
Request for Continued Examination
Nov 21, 2024
Response after Non-Final Action
Dec 03, 2024
Response after Non-Final Action
Mar 19, 2025
Non-Final Rejection — §103
Sep 16, 2025
Examiner Interview Summary
Sep 26, 2025
Response after Non-Final Action
Sep 26, 2025
Response Filed
Dec 01, 2025
Final Rejection — §103
Mar 02, 2026
Request for Continued Examination
Mar 06, 2026
Response after Non-Final Action
Mar 23, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582141
Polypeptides Having Phytase Activity
2y 5m to grant Granted Mar 24, 2026
Patent 12543762
FREEZE DRIED WHOLE ANIMAL PET FOOD
2y 5m to grant Granted Feb 10, 2026
Patent 12527336
NOVEL PALATABILITY-ENHANCING COMPOSITION
2y 5m to grant Granted Jan 20, 2026
Patent 12507714
METHODS AND COMPOSITIONS FOR INCREASING KETONE BODIES IN ANIMALS
2y 5m to grant Granted Dec 30, 2025
Patent 12478080
DIRECT-FED MICROBIALS AND METHODS OF THEIR USE
2y 5m to grant Granted Nov 25, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
22%
Grant Probability
38%
With Interview (+15.7%)
3y 10m
Median Time to Grant
High
PTA Risk
Based on 68 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month